Methyl 3-Hydroxyisoxazole-5-carboxylate, 97.0%, 25g

N-Butylbenzenesulfonamide, 95.0%, 25g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid, 95%, 100mg

6-Bromo-5-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 97%, 100mg

2-Ethyl-2,3-dihydrobenzofuran-2-carboxylic acid, 98%, 250mg

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinolin-2-ol, 95.0%, 1g

3-Azabicyclo[3.2.0]heptane-2,4-dione, 98%, 100mg

n-(2-Hydroxypropyl)acetamide, 97%, 250mg

GC capillary column ROTI®Cap-5, 50 m, 0.20 mm, 0.35 µm, 1 Piece(s)

1-(Quinolin-2-yl)ethanone, 95.0%, 100mg

N-benzyl-2-methylpropan-1-amine, 95.0%, 100mg

(3-(Piperidin-1-ylsulfonyl)phenyl)boronic acid, 98.0%, 1g

4-Amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide, 95.0%, 25g